Related references
Note: Only part of the references are listed.P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
Kirstine Nielsen et al.
BMC CANCER (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
Eric S Christenson et al.
LANCET ONCOLOGY (2020)
A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial)
Hiroyuki Okuyama et al.
NEUROENDOCRINOLOGY (2020)
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis
Melissa Frizziero et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Immunotherapy for pancreatic cancer: A 2020 update
Dimitrios Schizas et al.
CANCER TREATMENT REVIEWS (2020)
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
Paloma Cejas et al.
NATURE MEDICINE (2019)
FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation
Kihyun Lee et al.
CELL REPORTS (2019)
T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
Patrick A. Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer
Jair Bar et al.
LUNG CANCER (2019)
Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms
Massimo Milione et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2019)
Evaluation of KRAS Mutation Status in a Patient With Concomitant Pancreatic Neuroendocrine Neoplasm and Intraductal Papillary Mucinous Neoplasm
Takamichi Igarashi et al.
PANCREAS (2019)
Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs
Yang Lv et al.
ENDOCRINE CONNECTIONS (2018)
Liver and pancreas: do similar embryonic development and tissue organization lead to similar mechanisms of tumorigenesis?
Elsa Ghurburrun et al.
GENE EXPRESSION (2018)
Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3
Bjoern Konukiewitz et al.
HUMAN PATHOLOGY (2018)
Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model
Daniel Benten et al.
MOLECULAR CANCER RESEARCH (2018)
Characterization of the Neuroendocrine Tumor Immune Microenvironment
Annacarolina da Silva et al.
PANCREAS (2018)
Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification
Daigoro Takahashi et al.
SCIENTIFIC REPORTS (2018)
Gastroenteropancreatic Neuroendocrine Tumors
Mauro Cives et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Mechanosignalling via integrins directs fate decisions of pancreatic progenitors
Anant Mamidi et al.
NATURE (2018)
The Levels of Tumor Markers in Pancreatic Neuroendocrine Carcinoma and Their Values in Differentiation Between Pancreatic Neuroendocrine Carcinoma and Pancreatic Ductal Adenocarcinoma
Xiaoling Zhuge et al.
PANCREAS (2018)
Recapitulating and Deciphering Human Pancreas Development From Human Pluripotent Stem Cells in a Dish
Maja B. K. Petersen et al.
HUMAN EMBRYONIC STEM CELLS IN DEVELOPMENT (2018)
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi et al.
CLINICAL CANCER RESEARCH (2017)
Genetic and epigenetic drivers of neuroendocrine tumours (NET)
Annunziata Di Domenico et al.
ENDOCRINE-RELATED CANCER (2017)
Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas
Moritz Jesinghaus et al.
MODERN PATHOLOGY (2017)
Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20%
Bjoern Konukiewitz et al.
MODERN PATHOLOGY (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents
Marianne Pavel et al.
NEUROENDOCRINOLOGY (2017)
Foxa2 and Pdx1 cooperatively regulate postnatal maturation of pancreatic β-cells
Aimee Bastidas-Ponce et al.
MOLECULAR METABOLISM (2017)
Dramatic Response of a Metastatic Primary Small-Cell Carcinoma of the Pancreas to a Trial of Immunotherapy with Nivolumab: A Case Report
Justin Kenneth Ugwu et al.
CASE REPORTS IN ONCOLOGY (2017)
Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study
Susumu Hijioka et al.
CLINICAL CANCER RESEARCH (2017)
Pancreatic cancer: Stroma and its current and emerging targeted therapies
Janaiah Kota et al.
CANCER LETTERS (2017)
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas
Laura H. Tang et al.
CLINICAL CANCER RESEARCH (2016)
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study
Namrata Vijayvergia et al.
BRITISH JOURNAL OF CANCER (2016)
Aberrant Menin expression is an early event in pancreatic neuroendocrine tuniorigenesis
Wenzel M. Hackeng et al.
HUMAN PATHOLOGY (2016)
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Pancreatic cancer biology and genetics from an evolutionary perspective
Alvin Makohon-Moore et al.
NATURE REVIEWS CANCER (2016)
Human pancreas development
Rachel E. Jennings et al.
DEVELOPMENT (2015)
Familial Pancreatic Adenocarcinoma
Gloria M. Petersen
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas
Waki Hosoda et al.
VIRCHOWS ARCHIV (2015)
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz et al.
NATURE COMMUNICATIONS (2015)
A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics
Anguraj Sadanandam et al.
CANCER DISCOVERY (2015)
Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas A Clinicopathologic Analysis of 44 Cases
Olca Basturk et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Gastroenteropancreatic High-Grade Neuroendocrine Carcinoma
Halfdan Sorbye et al.
CANCER (2014)
Targeting mTOR dependency in pancreatic cancer
Douglas C. Morran et al.
GUT (2014)
Development of the Human Pancreas From Foregut to Endocrine Commitment
Rachel E. Jennings et al.
DIABETES (2013)
Evolution and dynamics of pancreatic cancer progression
S. Yachida et al.
ONCOGENE (2013)
Identification and Characterization of Poorly Differentiated Invasive Carcinomas in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
Karen E. Hunter et al.
PLOS ONE (2013)
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
Shinichi Yachida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Epidemiology of gastroenteropancreatic neuroendocrine tumours
M. Fraenkel et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Attenuation of the Retinoblastoma Pathway in Pancreatic Neuroendocrine Tumors Due to Increased Cdk4/Cdk6
Laura H. Tang et al.
CLINICAL CANCER RESEARCH (2012)
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments
Catharina M. Korse et al.
EUROPEAN JOURNAL OF CANCER (2012)
Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
Mitsuro Kanda et al.
GASTROENTEROLOGY (2012)
Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
Barbara Sennino et al.
CANCER DISCOVERY (2012)
Production of Functional Glucagon-Secreting alpha-Cells From Human Embryonic Stem Cells
Alireza Rezania et al.
DIABETES (2011)
Cystic precursors to invasive pancreatic cancer
Hanno Matthaei et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges
Laura Catena et al.
TARGETED ONCOLOGY (2011)
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
Milind M. Javle et al.
BMC CANCER (2010)
Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors
Takashi Shida et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases
Vincenzo Corbo et al.
ENDOCRINE-RELATED CANCER (2010)
Chromogranin-A and N-Terminal Pro-Brain Natriuretic Peptide: An Excellent Pair of Biomarkers for Diagnostics in Patients With Neuroendocrine Tumor
Catharina M. Korse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cancer-Stellate Cell Interactions Perpetuate the Hypoxia-Fibrosis Cycle in Pancreatic Ductal Adenocarcinoma
Mert M. Erkan et al.
NEOPLASIA (2009)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinorna by k-Ras Oncogenes in adult mice
Carmen Guerra et al.
CANCER CELL (2007)
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer
Takeo Nomi et al.
CLINICAL CANCER RESEARCH (2007)
Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role
M Cimitan et al.
ANNALS OF ONCOLOGY (2003)
Share Paper
